STOCK TITAN

[Form 4] Kestra Medical Technologies, Ltd. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Jabil Inc. (NYSE: JBL) – Form 144 filing: an unidentified insider intends to sell up to 13,432 common shares through UBS Financial Services. The proposed sale is scheduled to begin on 07/21/2025.

  • Aggregate market value: 3,000,000 (currency not specified in filing).
  • Shares outstanding: 107,318,837, so the planned sale represents roughly 0.01% of the float.
  • The shares were originally acquired in 2012 via the company’s Employee Stock Purchase Plan and Restricted Stock Units.
  • No sales by this filer have been reported in the past three months.

The filing is a routine notice required by Rule 144 and does not itself signal corporate developments. However, it discloses a modest insider intent to dispose of shares, which investors often monitor as a sentiment indicator.

Jabil Inc. (NYSE: JBL) – Presentazione del Modulo 144: un insider non identificato intende vendere fino a 13.432 azioni ordinarie tramite UBS Financial Services. La vendita proposta è prevista per iniziare il 21/07/2025.

  • Valore di mercato complessivo: 3.000.000 (valuta non specificata nella comunicazione).
  • Azioni in circolazione: 107.318.837, quindi la vendita pianificata rappresenta circa lo 0,01% del flottante.
  • Le azioni sono state originariamente acquisite nel 2012 tramite il Piano di Acquisto Azionario per Dipendenti e le Restricted Stock Units della società.
  • Non sono state segnalate vendite da parte di questo soggetto negli ultimi tre mesi.

La comunicazione è una notifica di routine richiesta dalla Regola 144 e non indica di per sé sviluppi societari. Tuttavia, rivela un modesto intento da parte di un insider di cedere azioni, un dato che gli investitori spesso monitorano come indicatore di sentiment.

Jabil Inc. (NYSE: JBL) – Presentación del Formulario 144: un insider no identificado tiene la intención de vender hasta 13,432 acciones comunes a través de UBS Financial Services. La venta propuesta está programada para comenzar el 21/07/2025.

  • Valor de mercado agregado: 3,000,000 (moneda no especificada en la presentación).
  • Acciones en circulación: 107,318,837, por lo que la venta planificada representa aproximadamente el 0.01% del flotante.
  • Las acciones fueron adquiridas originalmente en 2012 mediante el Plan de Compra de Acciones para Empleados y las Unidades de Acciones Restringidas de la compañía.
  • No se han reportado ventas por parte de este declarante en los últimos tres meses.

La presentación es una notificación rutinaria requerida por la Regla 144 y no indica desarrollos corporativos por sí misma. Sin embargo, revela una intención modesta de un insider de vender acciones, lo cual los inversores suelen monitorear como un indicador de sentimiento.

Jabil Inc. (NYSE: JBL) – Form 144 제출: 신원이 밝혀지지 않은 내부자가 UBS Financial Services를 통해 최대 13,432 보통주를 매도할 계획입니다. 예정된 매도는 2025년 7월 21일에 시작될 예정입니다.

  • 총 시장 가치: 3,000,000 (신고서에 통화 단위 미기재).
  • 발행 주식 수: 107,318,837주로, 계획된 매도는 유통 주식의 약 0.01%에 해당합니다.
  • 이 주식들은 2012년에 회사의 직원 주식 구매 계획과 제한 주식 단위를 통해 원래 취득되었습니다.
  • 이 신고자의 최근 3개월 내 매도 기록은 없습니다.

이 제출은 규칙 144에 따라 요구되는 일상적인 통지로, 그 자체로 기업의 변화를 나타내지 않습니다. 하지만 내부자가 소량의 주식을 처분하려는 의도를 공개하며, 투자자들은 이를 종종 시장 심리 지표로 주시합니다.

Jabil Inc. (NYSE : JBL) – Dépôt du formulaire 144 : un initié non identifié prévoit de vendre jusqu'à 13 432 actions ordinaires via UBS Financial Services. La vente proposée devrait débuter le 21/07/2025.

  • Valeur marchande totale : 3 000 000 (devise non précisée dans le dépôt).
  • Actions en circulation : 107 318 837, la vente envisagée représente donc environ 0,01 % du flottant.
  • Les actions ont été initialement acquises en 2012 via le Plan d’Achat d’Actions des Employés et les Restricted Stock Units de l’entreprise.
  • Aucune vente de la part de ce déclarant n’a été signalée au cours des trois derniers mois.

Le dépôt est une notification de routine requise par la règle 144 et ne signale pas en soi d’évolution d’entreprise. Cependant, il révèle une intention modeste d’un initié de céder des actions, ce que les investisseurs surveillent souvent comme un indicateur de sentiment.

Jabil Inc. (NYSE: JBL) – Einreichung des Formulars 144: Ein nicht identifizierter Insider beabsichtigt, bis zu 13.432 Stammaktien über UBS Financial Services zu verkaufen. Der geplante Verkauf soll am 21.07.2025 beginnen.

  • Gesamtmarktwert: 3.000.000 (Währung in der Einreichung nicht angegeben).
  • Ausstehende Aktien: 107.318.837, somit entspricht der geplante Verkauf etwa 0,01 % des Streubesitzes.
  • Die Aktien wurden ursprünglich 2012 über den Mitarbeiteraktienkaufplan und Restricted Stock Units des Unternehmens erworben.
  • In den letzten drei Monaten wurden keine Verkäufe dieses Melders gemeldet.

Die Einreichung ist eine routinemäßige Mitteilung gemäß Regel 144 und signalisiert für sich genommen keine unternehmerischen Entwicklungen. Sie offenbart jedoch eine geringe Absicht eines Insiders, Aktien zu veräußern, was von Investoren oft als Stimmungsindikator beobachtet wird.

Positive
  • None.
Negative
  • Insider selling: A company insider plans to dispose of 13,432 shares, which can be perceived as a slight negative sentiment signal even though the amount is immaterial to share count.

Insights

TL;DR: Small insider sale (13.4k shares, ~0.01% O/S); immaterial to fundamentals, mildly negative for sentiment.

The proposed disposition is insignificant relative to Jabil’s 107 M shares outstanding and carries a market value of about 3 M. The shares stem from ESPP and RSU grants dating back to 2012, suggesting normal portfolio diversification rather than a signal of operational weakness. No clustering of recent insider sales is disclosed, which lessens concern. Overall impact on valuation is negligible, but some investors may view any insider selling as a modest head-wind for near-term sentiment.

Jabil Inc. (NYSE: JBL) – Presentazione del Modulo 144: un insider non identificato intende vendere fino a 13.432 azioni ordinarie tramite UBS Financial Services. La vendita proposta è prevista per iniziare il 21/07/2025.

  • Valore di mercato complessivo: 3.000.000 (valuta non specificata nella comunicazione).
  • Azioni in circolazione: 107.318.837, quindi la vendita pianificata rappresenta circa lo 0,01% del flottante.
  • Le azioni sono state originariamente acquisite nel 2012 tramite il Piano di Acquisto Azionario per Dipendenti e le Restricted Stock Units della società.
  • Non sono state segnalate vendite da parte di questo soggetto negli ultimi tre mesi.

La comunicazione è una notifica di routine richiesta dalla Regola 144 e non indica di per sé sviluppi societari. Tuttavia, rivela un modesto intento da parte di un insider di cedere azioni, un dato che gli investitori spesso monitorano come indicatore di sentiment.

Jabil Inc. (NYSE: JBL) – Presentación del Formulario 144: un insider no identificado tiene la intención de vender hasta 13,432 acciones comunes a través de UBS Financial Services. La venta propuesta está programada para comenzar el 21/07/2025.

  • Valor de mercado agregado: 3,000,000 (moneda no especificada en la presentación).
  • Acciones en circulación: 107,318,837, por lo que la venta planificada representa aproximadamente el 0.01% del flotante.
  • Las acciones fueron adquiridas originalmente en 2012 mediante el Plan de Compra de Acciones para Empleados y las Unidades de Acciones Restringidas de la compañía.
  • No se han reportado ventas por parte de este declarante en los últimos tres meses.

La presentación es una notificación rutinaria requerida por la Regla 144 y no indica desarrollos corporativos por sí misma. Sin embargo, revela una intención modesta de un insider de vender acciones, lo cual los inversores suelen monitorear como un indicador de sentimiento.

Jabil Inc. (NYSE: JBL) – Form 144 제출: 신원이 밝혀지지 않은 내부자가 UBS Financial Services를 통해 최대 13,432 보통주를 매도할 계획입니다. 예정된 매도는 2025년 7월 21일에 시작될 예정입니다.

  • 총 시장 가치: 3,000,000 (신고서에 통화 단위 미기재).
  • 발행 주식 수: 107,318,837주로, 계획된 매도는 유통 주식의 약 0.01%에 해당합니다.
  • 이 주식들은 2012년에 회사의 직원 주식 구매 계획과 제한 주식 단위를 통해 원래 취득되었습니다.
  • 이 신고자의 최근 3개월 내 매도 기록은 없습니다.

이 제출은 규칙 144에 따라 요구되는 일상적인 통지로, 그 자체로 기업의 변화를 나타내지 않습니다. 하지만 내부자가 소량의 주식을 처분하려는 의도를 공개하며, 투자자들은 이를 종종 시장 심리 지표로 주시합니다.

Jabil Inc. (NYSE : JBL) – Dépôt du formulaire 144 : un initié non identifié prévoit de vendre jusqu'à 13 432 actions ordinaires via UBS Financial Services. La vente proposée devrait débuter le 21/07/2025.

  • Valeur marchande totale : 3 000 000 (devise non précisée dans le dépôt).
  • Actions en circulation : 107 318 837, la vente envisagée représente donc environ 0,01 % du flottant.
  • Les actions ont été initialement acquises en 2012 via le Plan d’Achat d’Actions des Employés et les Restricted Stock Units de l’entreprise.
  • Aucune vente de la part de ce déclarant n’a été signalée au cours des trois derniers mois.

Le dépôt est une notification de routine requise par la règle 144 et ne signale pas en soi d’évolution d’entreprise. Cependant, il révèle une intention modeste d’un initié de céder des actions, ce que les investisseurs surveillent souvent comme un indicateur de sentiment.

Jabil Inc. (NYSE: JBL) – Einreichung des Formulars 144: Ein nicht identifizierter Insider beabsichtigt, bis zu 13.432 Stammaktien über UBS Financial Services zu verkaufen. Der geplante Verkauf soll am 21.07.2025 beginnen.

  • Gesamtmarktwert: 3.000.000 (Währung in der Einreichung nicht angegeben).
  • Ausstehende Aktien: 107.318.837, somit entspricht der geplante Verkauf etwa 0,01 % des Streubesitzes.
  • Die Aktien wurden ursprünglich 2012 über den Mitarbeiteraktienkaufplan und Restricted Stock Units des Unternehmens erworben.
  • In den letzten drei Monaten wurden keine Verkäufe dieses Melders gemeldet.

Die Einreichung ist eine routinemäßige Mitteilung gemäß Regel 144 und signalisiert für sich genommen keine unternehmerischen Entwicklungen. Sie offenbart jedoch eine geringe Absicht eines Insiders, Aktien zu veräußern, was von Investoren oft als Stimmungsindikator beobachtet wird.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Ford Alfred J Jr

(Last) (First) (Middle)
C/O KESTRA MEDICAL TECHNOLOGIES, LTD.
3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)
KIRKLAND WA 98033

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Commercial Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 07/17/2025 A 29,412(1) A $0.00 29,412 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (2) (2) 03/06/2035 Common Shares 118,000 118,000 D
Explanation of Responses:
1. Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSU's will vest 9,804 on July 17, 2026, 9,804 on July 17, 2027 and 9,804 on July 17, 2028.
2. Includes 59,000 options that will vest on March 6, 2026, and the remaining 59,000 will vest monthly over the following year.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Alfred J. Ford, Jr. 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
KESTRA MED TECHNOLOGIES LTD

NASDAQ:KMTS

KMTS Rankings

KMTS Latest News

KMTS Latest SEC Filings

KMTS Stock Data

792.31M
10.00M
6.32%
50.37%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
KIRKLAND